T/ZGCIT 015-2024 Human umbilical cord mesenchymal stem cell clinical application guidelines for knee osteoarthritis
T/ZGCIT 015-2024 Human umbilical cord mesenchymal stem cell clinical application guidelines for knee osteoarthritis
Basic Information
Scope
Scope: This document specifies the requirements for institutions and personnel involved in the treatment of knee osteoarthritis with human umbilical cord mesenchymal stem cells, the process of obtaining human umbilical cord mesenchymal stem cells and local injection treatment, as well as the post-treatment examination, follow-up tracking, and monitoring procedures for patients. This document is applicable to orthopedics and arthroscopic surgery departments in general hospitals for the treatment of knee osteoarthritis caused by degenerative lesions using human umbilical cord mesenchymal stem cells. Main technical content: This document specifies the requirements for institutions and personnel involved in the treatment of knee osteoarthritis with human umbilical cord mesenchymal stem cells, the process of obtaining human umbilical cord mesenchymal stem cells and local injection treatment, as well as the post-treatment examination, follow-up tracking, and monitoring procedures for patients.